• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News

    MSF presses for action on drug-resistant TB

    By Ivy Mungcal // 22 March 2012
    A patient takes his TB drugs at a health center in Tanzania. Medecins Sans Frontieres urges governments, donors and the pharmaceutical industry for new campaigns to fight a deadlier form of tuberculosis. Photo by: Novartis AG / CC BY-NC-ND

    A concerted global effort is urgently needed to avert an “emerging global crisis of multi-drug resistant tuberculosis,” a leading medical humanitarian organization has said.

    Medecins Sans Frontieres, in a statement released ahead of World Tuberculosis Day (March 24), warned that the global scope of MDR-TB appears broader than previously estimated. The group is now pressing governments, donors and the pharmaceutical industry for new campaigns and funding to fight this deadlier form of the disease.

    The organization backed its call with “alarming new data” collected from its projects around the world. In a clinic in South Africa, for instance, MSF said it has seen a 211 percent increase in the number of TB diagnosis per month since the introduction of a new rapid diagnostic test. More than 13 percent of the confirmed TB cases were resistant to rifampicin, one of the most effective first-line TB treatment drugs.

    Outdated diagnostic tools, expensive medicine, inadequate funding and lack of proper drug regulation are only some of the factors that contribute to and complicate the problem, MSF said. The crisis is also fueled by lengthy treatment regiments that use toxic drugs, mostly with unpleasant side effects, the group added.

    “Far shorter and less toxic drug regimens are needed, along with currently non-existent formulations for children, and a point-of-care diagnostics test,” MSF said. “Regulatory measures need to be enforced to prevent further spread of the disease due to mismanagement by practitioners.”

    Meanwhile, the International HIV/AIDS Alliance, the Stop AIDS Campaign and the anti-poverty group Results UK released a joint statement a day before World Tuberculosis Day calling on governments to scale up funding for TB. They said 3.4 million patients will be left untreated and gains will be reversed if the $1.7 billion funding shortfall is not addressed. 

    Read more:

    • On the spotlight: Tuberculosis among children

    • Just unveiled: Tuberculosis vaccine research blueprint

    • TB, a ‘poverty disease’

    Read more development aid news online, and subscribe to The Development Newswire to receive top international development headlines from the world’s leading donors, news sources and opinion leaders — emailed to you FREE every business day.

    • Global Health
    • Funding
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Ivy Mungcal

      Ivy Mungcal

      As former senior staff writer, Ivy Mungcal contributed to several Devex publications. Her focus is on breaking news, and in particular on global aid reform and trends in the United States, Europe, the Caribbean, and the Americas. Before joining Devex in 2009, Ivy produced specialized content for U.S. and U.K.-based business websites.

    Search for articles

    Related Stories

    Global HealthStop TB Partnership retains US funds but must revise scope, cut staff

    Stop TB Partnership retains US funds but must revise scope, cut staff

    Global healthHow Trump’s aid freeze is threatening tuberculosis programs

    How Trump’s aid freeze is threatening tuberculosis programs

    Global HealthHow unregulated antibiotics are fueling drug-resistant UTIs

    How unregulated antibiotics are fueling drug-resistant UTIs

    Talking TB: Sponsored by Stop TB PartnershipOpinion: India’s bold leadership in turning the tide for TB

    Opinion: India’s bold leadership in turning the tide for TB

    Most Read

    • 1
      How low-emissions livestock are transforming dairy farming in Africa
    • 2
      The UN's changing of the guard
    • 3
      Opinion: Mobile credit, savings, and insurance can drive financial health
    • 4
      Opinion: India’s bold leadership in turning the tide for TB
    • 5
      Lasting nutrition and food security needs new funding — and new systems
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement